In breast cancer, CHAC1 overexpression promotes both proliferation and migration, while in ovarian cancer, its impact is primarily restricted to cell migration, with minimal effect on proliferation (Goebel et al., 2012). Here, CHAC1 is linked to ovarian carcinoma.